Site icon Smallcaps Daily

Tauriga Sciences, Inc. to Operate Corporate Exhibitor Table at The Hampton Cannabis EXPO 2021

[ad_1]

The Event Takes Place on Sunday, August 22, 2021 at The Club House Hamptons (East Hampton, New York): From 2:00pm to 9:00pm 

NEW YORK, NY – (NewMediaWire) – August 20, 2021 – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, has today announced that it will operate an “in-person” Corporate Exhibitor Table (“Table”) at The Hampton Cannabis EXPO 2021.  This event takes place on Sunday, August 22, 2021 at The Club House Hamptons (East Hampton, New York): from 2:00pm to 9:00pm EST.

 

DESCRIPTION BELOW:

Hampton Cannabis Expo 2021 is the Place to Meet with Investors and other Cannabis Industry Leaders Looking to Take Advantage of the Immense Business Opportunities Coming to NY and Beyond.

Enjoy Cocktails, Dinner, Exhibitors, Live Music, Panel Debates, Product Samples, After Party!

Link to Hampton Cannabis EXPO 2021:

https://hamptoncannabisexpo.com

In other news, the Company will also be operating a Corporate Exhibitor Booth at the AATAC Convenience Store Tradeshow 2021.  This event will take place on September 22nd-23rd, 2021 at the Richmond Raceway Complex (Richmond, Virginia). 

The Asian American Trade Associations Council (“AATAC”) is comprised of smaller buying groups, regional sub-chapters, independents, and other trade organizations under one blanket that consist of over 50,000 Operators controlling over 80,000 Retail Locations across the United States and Puerto Rico. Currently, there are approximately a little over 152,000 Convenience Stores (“C-stores”) in the country.

The Company’s Exhibitor Booth will include: 10ft x 10ft Main Floor Exhibitor Booth

Link: https://aatac.co/about-us/

The Company is focused on the national expansion of its enhanced Tauri-Gum™ product line.  The Company is aggressively marketing its propriety product lines in at least 5 major tradeshows before the end of calendar year 2021.

COMPLETE UPCOMING TRADESHOW SCHEDULE:

1)   HAMPTON CANNABIS EXPO 2021

·       August 22, 2021 (East Hampton, New York)

 2)  The AATAC C-STORE TRADESHOW

·       September 22-23, 2021 (Richmond, Virginia)

 3)  The WHITE LABEL WORLD EXPO

·       September 30, 2021 (New York City, New York)

4)  MJ BIZ CON 2021

·       October 20-22, 2021 (Las Vegas, Nevada)

5)  KOSHERFEST 2021

·       November 9-10, 2021 (Secaucus, New Jersey)

 

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant), (DELTA 8 THC Infused Tauri-Gum™ Flavor: Evergreen Mint), (Vitamin C + Zinc Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum™ Flavor: Golden Raspberry).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative.  This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company announced that it had Converted its U.S. Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.  On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company’s clinical development efforts.

The Company is headquartered in Wappingers Falls, New York.  In addition, the Company operates two full time E-Commerce fulfillment centers: one located in Montgomery, Texas and the other in Brooklyn, New York.

DISCLAIMER — Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Chief Executive Officer

Mr. Seth M. Shaw

Email: sshaw@tauriga.com

cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram: @sethsms47

Twitter: @SethMShaw

Corp. Website:   www.tauriga.com

E-Commerce Website:  www.taurigum.com

 

 

[ad_2]

Source link

Exit mobile version